Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Diabetologia|November 27, 2014
The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes studyKwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
The New England Journal of Medicine|November 10, 2025
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3Luke J Laffin, Stephen J Nicholls, Russell S Scott, et al.
Journal of Diabetes Investigation|August 22, 2024
Haptoglobin phenotype and levels in type 2 diabetes and effects of fenofibrateAndrzej S Januszewski, Hayden K Young, Kwok-Leung Ong, et al.
Diabetes & Vascular Disease Research|July 19, 2021
The relationship of neutrophil elastase and proteinase 3 with risk factors, and chronic complications in type 2 diabetes: A Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) sub-studyKwok-Leung Ong, Liang Wu, Andrzej S Januszewski, et al.
Scientific Reports|September 22, 2021
Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetesAndrzej S Januszewski, David Chen, Russell S Scott, et al.
Clinical Chemistry|June 14, 2017
Baseline Circulating FGF21 Concentrations and Increase after Fenofibrate Treatment Predict More Rapid Glycemic Progression in Type 2 Diabetes: Results from the FIELD StudyKwok-Leung Ong, Rachel O'Connell, Andrzej S Januszewski, et al.
Diabetes Research and Clinical Practice|February 23, 2026
Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudyAndrzej S Januszewski, Michael L H Huang, Abubakar Mangani, et al.
The Lancet. Diabetes & Endocrinology|March 3, 2018
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD studyBoris Waldman, Jean-Claude Ansquer, David R Sullivan, et al.
European Journal of Human Genetics : EJHG|October 23, 2003
The deleted in colorectal carcinoma (DCC) gene 201 R --> G polymorphism: no evidence for genetic association with autoimmune diseaseRichard J Hall, Marilyn E Merriman, Rachel A Green, et al.
The New England Journal of Medicine|May 26, 2026
In Vivo Base Editing of <i>PCSK9</i> with VERVE-102 for HypercholesterolemiaScott B Vafai, Jörg Täubel, Thomas Ashdown, et al.
Pageof 4